FeesSafety
Pluang+

Valens Semiconductor posts modest Q3 gains but ongoing losses and high costs keep sell rating intact

Company Fundamentals
11 Nov 2026, 21:41 WIB
Seeking Alpha
View Source
Bearish
Valens Semiconductor posts modest Q3 gains but ongoing losses and high costs keep sell rating intact

Valens Semiconductor showed some improvement in Q3, driven by a rebound in auto sales. However, expected growth from other industries and AI applications did not materialize, weakening the optimistic outlook. The company continues to face GAAP and EBITDA losses, along with high selling, general, and administrative (SG&A) and research and development (R&D) expenses. Additionally, shareholder dilution raises concerns, leading the analyst to maintain a sell rating despite modest progress in the automotive sector.

Valens Semiconductor provides context for technology sector trends. For readers following this sector, here is Pluang's market snapshot as of Nov 12, 2026 02:41 WIB: Out of 150 priced US tech stocks, 126 rose and 24 fell. Notable movers include VNET at USD 3.46 with a 15.33% increase, Dell Technologies at USD 376.98 up 12.76%, and Arm Holdings at USD 204.59 rising 12.73%. Typical hold times range from 17 to 58 days, with mixed buy-sell order activity.

More News

Global beverage market to reach $2.78T by 2032, driven by nonalcoholic drinks and convenience trends.

Global beverage market to reach $2.78T by 2032, driven by nonalcoholic drinks and convenience trends.

The global beverage market is projected to grow from $2.03 trillion in 2026 to $2.78 trillion by 2032, at a CAGR of 5.35%. Growth is fueled by rising demand for nonalcoholic and functional beverages, convenience packaging, and premium products for sp...

Market News
Bullish
1 hour ago
Over 200 GLP-1 and incretin therapies in development are reshaping diabetes and obesity treatment landscapes.

Over 200 GLP-1 and incretin therapies in development are reshaping diabetes and obesity treatment landscapes.

DelveInsight's 2026 report reveals more than 200 GLP-1 receptor agonists and incretin-based therapies are in development by over 180 companies, targeting conditions like type 2 diabetes, obesity, and related metabolic disorders. Key players such as E...

Bullish
1 hour ago
Dylanex offers key Q4 inventory tips for Amazon sellers to avoid stock-outs and manage holiday demand.

Dylanex offers key Q4 inventory tips for Amazon sellers to avoid stock-outs and manage holiday demand.

Dylanex has released practical guidance for Amazon sellers to prepare inventory for the busy Q4 holiday season. The advice focuses on managing inbound shipment timing, avoiding preparation errors, planning around restock limits, and using reserve sto...

Market News
Neutral
4 hours ago
Australia project logistics market to grow to $10.27B by 2031, driven by mining and renewable energy projects

Australia project logistics market to grow to $10.27B by 2031, driven by mining and renewable energy projects

The Australia project logistics market is projected to grow from USD 7.88 billion in 2026 to USD 10.27 billion by 2031, at a CAGR of 5.52%. Growth is fueled by mining and energy projects requiring transport of oversized cargo, and expanding renewable...

Market News
Bullish
4 hours ago
EIA raises 2027 US gas price forecast to $3.73/gal amid supply constraints, despite slight drop from 2026 levels.

EIA raises 2027 US gas price forecast to $3.73/gal amid supply constraints, despite slight drop from 2026 levels.

The U.S. Energy Information Administration (EIA) updated its forecast, projecting retail gasoline prices to average $3.73 per gallon in 2027, a 5% increase from last month's estimate but still lower than 2026's $3.89 per gallon. Diesel prices are als...

Market News
Neutral
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App